Table 2.

Associations between PLIN polymorphisms and the risk of type 2 diabetes by central obesity

		No. (%)		Odds Ratio
		Cases	Controls	(95% CI)
Non-obese
rs2289487	TT	62 (32.6)	210 (38.5)	1
	TC	91 (47.9)	262 (48.0)	1.35 (0.89–2.04)
	CC	37 (19.5)	74 (13.5)	2.18 (1.26–3.78)
	TC+CC			1.52 (1.03–2.25)
rs8179043	CC	82 (42.0)	279 (50.1)	1
	CT	91 (46.7)	225 (40.4)	1.51 (1.03–2.23)
	TT	22 (11.3)	53 (9.5)	1.67 (0.91–3.08)
	CT+TT			1.54 (1.07–2.23)
rs894160	GG	86 (44.3)	285 (51.8)	1
	GA	90 (46.4)	218 (39.6)	1.55 (1.05–2.28)
	AA	18 (9.3)	47 (8.6)	1.67 (0.87–2.21)
	GA+AA			1.57 (1.09–2.27)
Obese
rs2289487	TT	98 (44.9)	81 (38.4)	1
	TC	94 (43.2)	95 (45.0)	0.89 (0.57–1.41)
	CC	26 (11.9)	35 (16.6)	0.60 (0.31–1.13)
	TC+CC			0.81 (0.53–1.24)
rs8179043	CC	118 (53.7)	97 (45.8)	1
	CT	83 (37.7)	95 (44.8)	0.79 (0.51–1.23)
	TT	19 (8.6)	20 (9.4)	0.70 (0.33–1.47)
	CT+TT			0.78 (0.51–1.18)
rs894160	GG	116 (53.7)	100 (47.6)	1
	GA	81 (37.5)	92 (43.8)	0.82 (0.53–1.28)
	AA	19 (8.8)	18 (8.6)	0.80 (0.38–1.70)
	GA+AA			0.82 (0.54–1.24)

Adjusted for age and BMI, cigarette smoking, alcohol consumption, physical activity, and menopausal status.